Level B· Emerging clinical evidence with positive signalsClinical TrialPubMed

Stem Cells in Male Sexual Dysfunction: Are We Getting Somewhere?

Soebadi MA., Milenkovic U., Weyne E., Castiglione F., Albersen M.

Clinical Trial on Systemic / IV, published in Sex Med Rev (2016) — summary generated from the PubMed abstract.

Open my reading list
Level B· Emerging clinical evidence with positive signalsEvidence level of this study

Several human studies show positive signals, while research methods and sample sizes continue to develop.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Clinical Trial
Journal
Sex Med Rev (2016)
Country
Netherlands
Reported sample size
—
Source database
PubMed
PMID
28041853
DOI
10.1016/j.sxmr.2016.11.002
Citations
23

Abstract (original English)

Introduction Stem cells for sexual disorders are steadily being introduced into clinical trials. Two conditions of importance are the main target for this line of treatment, especially when regarding the wide array of translational and basic science highlighting the potential advantages of regenerative therapy: erectile dysfunction (ED) and more recently Peyronie disease (PD). Cellular therapy offers a treatment modality that might reverse disease progression. It would be used in a curative setting, in contrast to other pharmaceutical agents that are currently available. Aim To review basic preclinical studies and recent clinical trials of stem cells on ED and PD. Methods A search of the medical literature for the following terms was performed using PubMed: stem cells, cellular therapy, erectile dysfunction, Peyronie's disease, and clinical trial. Main outcome measures A non-systematic narrative review and critical reflection on preclinical and clinical studies administering stem cells for ED and PD in animal models and human subjects. Results Numerous studies have confirmed the beneficial functional effects of stem cell injection in established animal models on ED and PD. Various stem cell types have been adopted, from embryonic to adult mesenchymal cell types. Each cell type offers distinctive advantages and disadvantages. Diverse administrations of stem cells were investigat

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.

Evidence level

Several human studies show positive signals, while research methods and sample sizes continue to develop.

How we grade evidence
AnimalsHumansMaleAgingClinical Trials as TopicDiabetes ComplicationsErectile DysfunctionMetabolic SyndromePenile DiseasesProstatectomy

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research